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ABSTRACT 
Coronary stent implantation can improve blood flow in an 
artery narrowed by the build up of arterial plaque. However, 
the haemodynamic effect of stent placement is unclear and 
may influence arterial restenosis (re-blockage). In this 
investigation computational fluid dynamics (CFD) was used 
to predict the non-Newtonian three-dimensional flow field in 
a coronary artery following implantation of two different 
stents. A graphical illustration of the stented areas affected to 
various degrees of wall shear stress (WSS) is presented for 
both the Palmaz-Schatz (PS) and the Gianturco-Roubin-II 
(GR-II) coronary stents. The axial WSS and wall shear stress 
gradient (WSSG) is also presented graphically over one stent 
strut for each stent. Finally, a comparison is drawn between 
the CFD results and restenosis data from a clinical trial.  
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1. Introduction 
 
Coronary artery disease (CAD) is one of the leading causes 
of death in the developed world. CAD occurs due to the 
build up of plaque in the coronary arteries which supply 
fresh blood to the constantly active heart muscle. This build 
up of plaque, a condition known as atherosclerosis, deprives 
the heart muscle of its crucial supply of oxygen and nutrients 
provided by the coronary blood supply. In the past a 
coronary artery bypass graft was the only treatment available 
for CAD. This is a large scale operation involving the 
sawing open of the breastbone and grafting of a blood vessel 
to bypass the site of the blockage.  
Percutaneous transluminal coronary angioplasty (PTCA) 
was introduced in the late 1970s as a minimally invasive 
procedure to relieve the narrowing in a coronary artery due 
to the build up of plaque. PTCA is accomplished with a 
small balloon catheter inserted into an artery in the groin or 
arm, and advanced to the narrowing in the coronary artery. 
The balloon is then inflated to enlarge the narrowing in the 
artery and restore blood flow to the heart muscle. However 
in over 40% of patients treated with PTCA the artery 
becomes re-blocked within six months in a process known as 
restenosis [1]. This is largely due to elastic recoil of the 
vessel wall [2]. 
In the early 1990s stents were introduced to improve the 
success rates of PTCA. Basically, a stent is an expandable, 
slotted metal tube inserted into the artery. It acts as a 
scaffold to provide support for the artery and has proven 
effective at eliminating elastic recoil, one mechanism of 
restenosis that can result in re-blockage [2]. The use of stents 
has shown more promising clinical outcomes than PTCA 
alone. However, restenosis remains a persistent problem 
with restenosis rates generally as high as 20% at six months 
after intervention [3].  
The changes in WSS induced by an implanted stent play a 
significant role in the immunological behaviour of the 
coronary artery. This behaviour is directly linked to 
restenosis within the stented artery [4, 5]. In order to assess 
the haemodynamic impact of coronary stent implantation, 
three-dimensional computational models of a stented left 
anterior descending (LAD) coronary artery have been 
created using computer-aided-design. One model represents 
the artery implanted with a PS stent and the second model 
represents the artery implanted with a GR-II stent. CFD was 
used to simulate the flow field of the coronary artery with 
the implanted stent in each case. 
Results are shown of the mesh convergence studies 
conducted. Contour plots and graphs of areas of high and 
low WSS and a graph of the axial WSSG in the vicinity of 
struts for both stents are also presented. The GR-II stent has 
been shown to perform poorly against the PS stent in a 
recent medical trial. The CFD results presented suggest that 
this poor performance is a direct result of the stent induced 
haemodynamic factors. 
 
 
2. Stents  
 
2.1 Introduction 
Stents are small tubular prostheses that serve the purpose of 
maintaining an adequate inner diameter of a narrowed blood 
vessel to allow for the comfortable passage of the blood. In 
1986 Jacques Puel and Ulrich Sigwart implanted the first 
coronary wallstents in Toulouse, France. Today over 1 
million stents are implanted worldwide each year. A stent is 
mounted on a balloon-tipped catheter, threaded through the 
artery, and positioned at the site of the blockage. As shown 
in Figure 1 the balloon is then inflated, opening the stent. 
Subsequently, the catheter and deflated balloon are removed, 
leaving the stent lodged in place against the inner lining of 
the artery. 
 
 
Figure 1: The stenting procedure for a narrowed artery. 
 
2.2 Stent Design 
The two stent designs modelled using CFD are shown in 
Figures 2 and 3 below. The first is the PS coronary stent 
manufactured by Johnson and Johnson. The stent is 15 mm 
long, consisting of two 7 mm sections joined by a 1 mm 
bridge. It ranges from 3 mm to 4 mm in diameter and is a 
slotted tube balloon expandable design. The second type of 
stent is the GR-II which is manufactured by Cook. The GR-
II stent has a balloon expandable coil design and is produced 
in 20 mm and 40 mm lengths ranging from 2.5 mm to 4 mm 
in diameter. 
  
 
Figure 2: The Palmaz-Schatz coronary stent developed by Johnson and 
Johnson. 
 
 
Figure 3: The Gianturco-Roubin II coronary stent developed by Cook. 
 
2.3 Mechanism of Stent Restenosis 
The implantation of a coronary stent leads to vascular injury 
and haemodynamic effects which may result in restenosis. 
Under normal healthy conditions vascular smooth muscle 
cells (VSMC) reside in the lunica media which is shown in 
the arterial cross section in Figure 4. Stent restenosis occurs 
when VSMC migrate through the lunica intima which is the 
inner lining of the artery wall, and build up in the artery 
lumen restricting the blood flow, a process known as 
neointimal hyperplasia (NH). The main components that 
determine the degree of restenosis that will occur are the 
blood clotting platelets which flow through the artery lumen 
and the endothelial cells (EC) which form the lunica intima.  
Platelets flowing in the artery lumen will bind together to 
form a blood clot if they become activated. Platelets can be 
activated through contact with a number of different 
substances such as thrombin or platelet derived growth 
factor (PDGF). Activated platelets will themselves release 
these substances to activate platelets around them. However, 
PDGF also has the effect of triggering NH. It has been 
documented that the platelet deposition near the stent in the 
first twelve hours after stenting is a major indicator of the 
amount of NH that will occur [6].  
 
 
Figure 4: Cross section of a coronary artery. 
 
Platelets and endothelial cells are directly affected by the 
shear force exerted by the flowing blood on the artery lumen 
wall known as WSS. It has been shown in a two-dimensional 
CFD study that areas of low velocity flow and low WSS 
exist in the vicinity of newly implanted stent wires [7]. The 
platelet deposition and residence times are much higher in 
these stagnation areas. This leads to platelet accumulation in 
the area around the stent wire leading to increased NH 
formation. The stent induced changes in the haemodynamics 
of the coronary flow also lead to an alteration of the WSS 
exerted on the EC [5, 8]. WSS has been shown to have a 
significant effect on the behaviour of EC [9]. A healthy 
value for WSS in a coronary artery is approximately 1.5 
Pascals [10]. When EC are subjected to values of WSS 
lower than this they begin to release adenosine diphosphate 
and triphosphate which induces platelet activation leading to 
blood clotting and NH formation [9]. Conversely, when 
endothelial cells are subjected to areas of "healthy" WSS 
they secrete nitrous oxide (NO) which inhibits adhesion of 
platelets to the vessel wall and VSMC growth, hence 
inhibiting NH formation [10]. Numerous studies have shown 
a link between areas of low WSS and increased NH [4, 5]. 
The success of a stenting procedure relies heavily on the 
reendothelialisation of the vessel wall after implantation and 
the successful function of the newly formed endothelial cells 
to inhibit platelet deposition. If a new layer of EC 
successfully grows over the stent the NH formation will 
cease. In a study to demonstrate the effect of wall shear 
stress gradients (WSSG), EC were exposed to a region of 
separated flow. After 48 hours the major finding was that in 
the area of the highest WSSG the EC density was up to 40% 
less than experimental controls [11]. Through the inhibition 
of reendothelialisation, high WSSG contribute to NH 
formation [5].  
EC will be damaged by the stenting procedure leading to the 
release of platelet activating substances and NH formation. 
A relationship has been established between vascular injury 
and NH [12]. 
Areas of low WSS, areas of high WSSG, and vascular injury 
at the time of stent implantation are the main contributors to 
NH formation. In light of this, disturbances to the coronary 
blood flow and the degree of trauma to the vessel wall due to 
stent implantation cannot be overlooked in future stent 
design. 
 
 
3. CFD Analysis 
 
3.1 Introduction 
CFD is a process whereby real-life fluid flows are simulated 
using numerical methods to solve the governing equations of 
fluid dynamics. CFD is a relatively new branch of fluid 
dynamics commonly regarded as the "third" technique for 
solution of fluid flow problems, complementing, but not 
replacing the well-established approaches of theory and 
experiment. CFD finds it niche in modelling fluid flows that 
are difficult or impossible to model using theory and are 
complex, time consuming or expensive to measure 
experimentally.  
 
3.2 The Computational Model 
In both computational models a cylindrical domain was 
created and the stent design cut from the domain to simulate 
conditions of the stent semi-embedded in the artery wall. 
One of the 7 mm sections of the PS stent was modelled and a 
half section of the 20 mm long GR-II stent was modelled. 
The domain extended 2.5 mm proximal (upstream) and 2.5 
mm distal (downstream) of the stent in each case to capture 
the flow field in those regions. 
 
 
Figure 5: Computational domain representing the left anterior 
descending coronary artery with implanted PS stent. 
3.3 Governing Equations of Fluid Mechanics 
Both simulations involved steady laminar flow which 
requires the CFD code to solve the conservation of mass and 
momentum equations, of which the general form are listed as 
Equations (1) and (2) respectively: 
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  (1) 
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where ρ  is the fluid density, p is the static pressure, V

is the 
velocity vector, F

 represents external body forces such as 
gravity, µ is the fluid dynamic viscosity and τ is the shear 
stress tensor given by Equation (3): 
 
( )TV Vτ µ= ∇ + ∇    (3) 
 
At low shear rates blood exhibits the non-Newtonian 
behaviour of variable dynamic viscosity which is dependant 
on the shear rate. The non-Newtonian nature of the flow is 
accommodated by using the Carreau model [13] given in 
Equation (4):  
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where γ is the rate of deformation tensor given by Equation 
(5) for a three-dimensional Cartesian coordinate system 
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  (5) 
 
and the constants for the Carreau model given below have 
been established from experimental data [13]: 
 
0 0.056 Pa.s 3.31 s
0.00345 Pa.s 0.375q
µ λ
µ
∞
= =
= =
       (6)    
 
The highly sophisticated commercial software code CFXTM 
was used to solve the governing equations of fluid 
mechanics for non-Newtonian blood flow in the 
computational domain using a vertex-centred finite volume 
scheme.  
 
3.4 Boundary Conditions 
The same boundary conditions were applied at the inlet, 
outlet and on the walls for both simulations.  
 
3.4.1 Inlet Boundary 
A fully developed axial velocity profile was applied at the 
inlets given by: 
 
2
21Max
rV V
R
 
= − 
 
  (7) 
 
where the variable r is the radius measured from the 
centreline at any point on the inlet plane and R is the radius 
at the wall of the domain. VMax is the maximum centreline 
velocity given a value of 0.412 m/s in Equation (7) to 
simulate resting conditions in the LAD coronary artery [14].  
 
3.4.2 Outlet Boundary 
A static pressure of zero Pascals was applied at the outlets of 
the both domains, allowing the software to calculate the 
velocity at these planes.
   
 
3.4.3 Wall Boundary 
The no-slip boundary condition was applied on all surfaces 
representative of the artery wall and the stent wires. 
 
3.5 Computational Mesh 
Analytical solutions to the governing equations of fluid 
mechanics exist for only the simplest of flows under ideal 
conditions. To obtain solutions for real flows a numerical 
approach must be adopted whereby the equations are 
replaced by algebraic approximations which may be solved 
using a numerical method. To achieve this, the 
computational domain must be divided into a set of much 
smaller non-overlapping sub-domains called elements which 
constitute the mesh. To obtain an accurate solution a 
sufficient number of elements must be placed in the 
computational domain. Figure 6 shows the fine mesh 
employed in the area around the PS stent wires. 
 
 
Figure 6: Computational mesh in the vicinity of a PS stent strut. 
 
 
4. Results 
 
4.1 Mesh Convergence Study 
A mesh convergence study was carried out to establish the 
required mesh density for accurate solutions, such that any 
increase in nodes would lead to no appreciable difference in 
the solution. Mesh convergence was achieved for both 
simulations by sequentially increasing the number of nodes 
until there was no appreciable difference in the axial 
distribution of WSS across one of the stent struts between 
the solutions.  
 
 
Figure 7: PS Stent strut and sample line upon which mesh convergence 
study was carried out. 
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Figure 8: Axial distributions of WSS across a PS stent strut as 
calculated by successively refined computational meshes. 
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Figure 9: Axial distributions of WSS across a GR-II stent strut as 
calculated by successively refined computational meshes. 
 
4.2 Wall Shear Stress Results 
The predicted three-dimensional flow field reveals areas of 
high WSS on the tops of the stent struts and low WSS 
immediately proximal and distal to the stent struts, 
particularly those transversal to the blood flow as shown in 
Figures 10 and 11. Figure 12 illustrates the percentage 
stented area subjected to WSS below a given magnitude 
starting from 0.1 Pascals. In comparison to the PS stent, the 
GR-II stent has more than double the percentage stented area 
subjected to WSS less than 0.1 and 0.25 Pascals, and 70% 
more percentage stented area subjected to less than 0.5 
Pascals. The GR-II stent also has areas on the stent wires 
with higher WSS than the PS stent with a maximum WSS 
value of 4.28 Pascals compared to the PS stent which has a 
maximum of 3.73 Pascals. 
 
 
Figure 10: Contour map of WSS in the vicinity of the implanted PS 
coronary stent. 
 
 
Figure 11: Contour map of WSS in the vicinity of implanted GR-II 
coronary stent. 
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Figure 12: Bar chart illustrating percentage stented area subjected to 
varying degrees of WSS for the GR-II and PS stent 
Figures 13 and 14 show the axial distribution of WSS and 
WSSG over one stent strut transversal to the flow direction 
which is where the maximum WSSG appears as shown in 
Figures 10 and 11. The magnitude of low WSS on both sides 
of the strut is similar for both stents. However, the GR-II 
stent displays 15% higher WSS on the top of the stent strut 
than the PS stent leading to a 21% higher WSSG in front of 
the stent strut and a 44% increase in WSSG behind the strut. 
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Figure 13: Distribution of WSS and WSSG in the axial direction over 
one of the PS stent struts. 
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Figure 14: Distribution of WSS and WSSG in the axial direction over 
one of the GR-II stent struts. 
 
 
5. Conclusion 
 
It is clear that haemodynamics of the flow in an artery 
implanted with a stent have an effect on the immunological 
response within the vessel wall of that artery. This work has 
demonstrated that stent design has an effect on those 
haemodynamic characteristics.  
In a medical trial conducted to compare the in vivo 
performance of these two stents, the GR-II stent had a 
restenosis rate of 47.3% compared to the PS restenosis rate 
of 20.6% after six months [15]. Areas of low WSS and high 
WSSG have earlier been identified as factors which 
encourage the development of NH which leads to restenosis. 
The CFD results predict that implantation of the GR-II stent 
rather than the PS stent would produce 70% more percentage 
stented area subjected to WSS below a value of 0.5 Pa. 
Implantation of a GR-II stent would also lead to up to 44% 
more WSSG around the stent struts. The medical trial data 
and predicted CFD results correlate strongly with the 
hypothesis that coronary haemodynamics due to stent design 
are a significant factor in whether or not the stenting 
procedure will be successful. In light of this evidence, future 
stent designs should strive to reduce restenosis encouraging 
haemodynamic effects, primarily regions of low WSS and 
high WSSG.  
This work has demonstrated the ability of applied computer 
science to provide the biomedical community with insights 
into complex haemodynamics that can be used to assist in 
the development of optimal stent designs for the future. 
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